Nephros, Inc.
NEPH
$3.42
-$0.13-3.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 558.00K | 349.00K | 183.00K | -289.00K | -169.00K |
| Total Depreciation and Amortization | 40.00K | 35.00K | 33.00K | 35.00K | 34.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 182.00K | 550.00K | 100.00K | 15.00K | 186.00K |
| Change in Net Operating Assets | -458.00K | 370.00K | -939.00K | -262.00K | -723.00K |
| Cash from Operations | 322.00K | 1.30M | -623.00K | -501.00K | -672.00K |
| Capital Expenditure | -- | 0.00 | 0.00 | -55.00K | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 5.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | -50.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00K | -1.00K | 0.00 | -2.00K | -2.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.00K | -1.00K | 0.00 | -2.00K | -2.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 321.00K | 1.30M | -623.00K | -553.00K | -674.00K |